SMTI · Sanara MedTech Inc. · Metrics
$32.77
-0.37 (-1.12%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$304.49M
Shares
9.19M
Volume · Oct 21
55.95K
Avg daily vol (3M)
293.97K
SMTI metrics
96 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$32.77
Market cap
$304.49M
Price action
20 metricsPrice change (1W)
-5.7%
Price change (30D)
-5.8%
Price change (3M)
+30.0%
Price change (6M)
+67.4%
Price change (YTD)
+41.9%
Price change (1Y)
+12.3%
Trailing year
Price change (5Y)
-3.2%
52-week high
$35.28
52-week low
$16.34
Change from 52-week high
-6.1%
Change from 52-week low
+102.8%
Annualized volatility
58.1%
Annualized volatility (3M)
38.7%
Beta
0.6
RSI (14D)
21.5
Price vs SMA 50
-4.6%
Price vs SMA 200
+31.9%
Avg volume (3M)
294,203
Relative volume
0.3
Average dollar volume
$10.04M
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
9.19M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.1×
reciprocal yield 32.7%
EV / EBITDA
28.5×
reciprocal yield 3.5%
EV / EBIT
39.9×
reciprocal yield 2.5%
P / sales
2.8×
reciprocal yield 36.1%
P / book
38.3
reciprocal yield 2.6%
FCF yield
1.5%
TTM · current market cap
Buyback yield
—
P / FCF
67.6
reciprocal yield 1.5%
P / operating cash flow
53.5
reciprocal yield 1.9%
Earnings yield
-10.5%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.3×
reciprocal yield 30.5%
EV / revenue historical average (5Y)
3.9×
reciprocal yield 26.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
146.0×
reciprocal yield 0.7%
EV / EBITDA historical average (5Y)
146.0×
reciprocal yield 0.7%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-05-12
Profitability
9 metricsGross margin
93.0%
Operating margin
7.7%
Trailing 12 months
Net margin
-29.2%
Gross profit (TTM)
$102.16M
Operating profit (TTM)
$8.42M
Net income (TTM)
−$32.01M
Trailing 12 months
Diluted EPS (TTM)
$-3.72
FCF margin
4.1%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+9.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$109.81M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-3.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+31.0%
Revenue CAGR (5Y)
+45.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-403.0%
Return on assets
-46.3%
Debt / equity
5.9
Current ratio
2.6
EBITDA (TTM)
$11.76M
Free cash flow (TTM)
$4.50M
Quick ratio
2.3
Interest coverage
1.2
Net debt / EBITDA
2.6
Return on invested capital
—
Trailing 12 months
Net cash
−$31.06M
Latest balance sheet
Cash & equivalents
$15.42M
Total assets
$69.15M
Total debt
$46.48M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$5.69M
Capital expenditures (TTM)
$1.19M
R&D (TTM)
$4.98M
SG&A (TTM)
$84.44M
Stock compensation (TTM)
$4.94M
R&D / revenue
4.5%
Stock compensation / revenue
4.5%
Ownership (13F)
9 metrics13F filers
74
13F filer change QoQ
+8
Institutional ownership
19.4%
Conviction holders (share of 13F filers)
1.4%
Crowding (high-turnover and private-fund holders)
6.2%
Private-fund adviser ownership
5.3%
Active holders' share change QoQ
+19.7%
Holder tenure
7.2
Price vs estimated holder cost
-14.8%
Ownership (registered funds)
1 metricsIndex-fund ownership
4.8%
Short interest
3 metricsShort interest
3.9%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
56 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—